Spanish IT Stock News

BME:GRF
BME:GRFBiotechs

Grifols (BME:GRF) Q1 EPS Slowdown Tests Bullish Margin Expansion Narrative

Grifols (BME:GRF) opened Q1 2026 with revenue of €1.7b and net income of €73m, translating into basic EPS of €0.11, while the trailing 12 month figures show revenue of €7.4b, net income of €415m and EPS of €0.61. The company has seen quarterly revenue move across a range from €1.79b in Q1 2025 to €1.98b in Q4 2025, with basic EPS figures of €0.10 in Q4 2024 and €0.14 in Q4 2025 before landing at €0.11 this quarter. This puts margins and earnings quality at the center of the discussion for...
BME:MEL
BME:MELHospitality

Meliá Hotels International (BME:MEL) Margin Improvement To 8.2% Tests Growth Concerns

Meliá Hotels International (BME:MEL) has just wrapped up FY 2025 with fourth quarter revenue of €469.9 million and basic EPS of €0.09, capping a trailing twelve month run of €2.1 billion in revenue and EPS of €0.77, alongside an 8.2% net margin compared with 7% a year earlier. Over the past few quarters, revenue has ranged from €444.5 million to €616.6 million with quarterly EPS between €0.03 and €0.34, giving you a clear view of how the earnings power has built through the year. With margins...
BME:RJF
BME:RJFPharmaceuticals

Reig Jofre (BME:RJF) Margin Compression To 1.5% Tests Bullish Earnings Narratives

Laboratorio Reig Jofre (BME:RJF) has just wrapped up FY 2025 with fourth quarter revenue of €94.7m and net income of €3.1m, translating to Basic EPS of €0.04. The trailing 12 month figures show revenue of €336.7m and net income of €5.0m, with Basic EPS of €0.06. Over recent quarters, revenue has ranged from €72.8m to €94.7m, and quarterly net income has moved between a loss of €2.1m and a profit of €3.7m. This sets up a picture where investors are likely to focus on how consistent margins...
BME:FDR
BME:FDRMachinery

Is Fluidra (BME:FDR) Offering Value After Recent Share Price Pullback?

This article examines whether Fluidra at €19.23 is a bargain or fairly priced by exploring what the current market is implying about the stock's value. The share price has seen mixed returns, with a 3.3% decline over the last 7 days and a 10.0% decline over the past month, while the 3-year return sits at 22.9% and the 5-year return at a 31.4% decline. Recent coverage has focused on how Fluidra's share price performance compares with the broader machinery sector and how investor expectations...
BME:SAN
BME:SANBanks

Santander Reshapes UK Story As TSB Brand Ends And Branches Close

Santander plans to retire the TSB brand from UK high streets after a takeover, folding TSB into Santander UK. The bank is set to close 26 UK branches as part of a wider shift toward digital banking services. The restructuring is aimed at cutting costs and reshaping Santander's UK presence, with direct effects on staff and customers. Banco Santander (BME:SAN) is acting on a material change to its UK footprint as it integrates TSB and accelerates branch closures. The stock trades at €10.466,...
BME:AMS
BME:AMSHospitality

Amadeus IT Group (BME:AMS) Valuation Check As Q1 2026 Results And IDEMIA Deal Shape The Outlook

Amadeus IT Group (BME:AMS) is back in focus after reporting first quarter 2026 results, with sales of €1,682.6 million and net income of €357 million, alongside ongoing buybacks and the planned IDEMIA Public Security acquisition. See our latest analysis for Amadeus IT Group. Despite the solid Q1 figures, the share price has had a mixed run, with a 1 month share price return of 5.46% and a year to date share price decline of 18.94%, contributing to a 1 year total shareholder return decline of...
BME:GRF
BME:GRFBiotechs

Is Grifols (BME:GRF) Pricing Reflect Recent Governance Concerns Or A Longer Term Opportunity?

Wondering whether Grifols at around €9.16 a share is offering genuine value or just looks cheap on the surface? This article walks through what the current price might actually be telling you. The stock has returned 2.2% over the last week and 1.2% over the last month, while the year to date return sits at an 18.2% decline and the 1 year return is 13.3%, set against a 16.1% decline over 3 years and a 59.8% decline over 5 years. Recent headlines around Grifols have focused on its balance...
BME:ELE
BME:ELEElectric Utilities

Endesa (BME:ELE) EPS Jump To €0.70 Challenges Cautious Growth Narratives

Endesa (BME:ELE) opened Q1 2026 with revenue of €5.8b and basic EPS of €0.70, setting the tone for how investors will read the latest move in profitability. The company reported quarterly revenue of €5.8b in both Q1 2025 and Q1 2026, while EPS increased from €0.55 to €0.70 over the same period, providing a clearer view of how earnings are tracking against a broadly stable top line. With trailing net margins above last year and earnings growth running ahead of revenue, this update places...
BME:ROVI
BME:ROVIPharmaceuticals

Rovi (BME:ROVI) Margin Strength In Q4 EPS Beat Tests Bearish CDMO Narrative

Laboratorios Farmaceuticos Rovi (BME:ROVI) has capped FY 2025 with fourth quarter revenue of €218.4 million and basic EPS of €0.83, while trailing 12 month figures show revenue of €743.5 million and EPS of €2.75 alongside net income of €140.4 million. The company has seen quarterly revenue move from €199.1 million in Q4 2024 to €218.4 million in Q4 2025, with net income rising over the same period from €23.4 million to €42.7 million, setting up a story where margins and earnings power sit...
BME:YGMP
BME:YGMPREITs

GMP Property SOCIMI (BME:YGMP) One Off Gain Challenges Earnings Quality Narratives

Earnings snapshot and context GMP Property SOCIMI (BME:YGMP) has released its H1 2025 figures, reporting total revenue of €57.2 million and basic EPS of €5.97, alongside a very large 12‑month profit swing that management attributes in part to a €138.0 million one‑off gain. Over recent half‑year periods, the company reported revenue of €49.2 million and EPS of €3.74 in H1 2024, compared with €57.2 million and EPS of €5.97 in H1 2025, while H2 2023 revenue was €49.8 million with an EPS loss of...
BME:EBRO
BME:EBROFood

Ebro Foods (BME:EBRO) Valuation Check After Q1 Profit Growth And Softer Sales

Q1 earnings snapshot and why it matters for Ebro Foods (BME:EBRO) Ebro Foods (BME:EBRO) opened the year with first quarter sales of €755.48 million versus €791.96 million a year earlier, while net income reached €52.95 million compared with €50.3 million. This combination may reshape how you think about the stock. See our latest analysis for Ebro Foods. The share price sits at €18.28, with a 30 day share price return of a 2.66% decline and a year to date share price return of a 0.98% decline...
BME:FCC
BME:FCCCommercial Services

A Look At Fomento de Construcciones y Contratas (BME:FCC) Valuation After Its Q1 2026 Earnings Call

The Q1 2026 earnings call for Fomento de Construcciones y Contratas (BME:FCC) on April 30 has put fresh attention on the stock, as investors reassess recent returns alongside the company’s latest operating update. See our latest analysis for Fomento de Construcciones y Contratas. The Q1 2026 earnings call appears to have been a key catalyst for the recent move, with the 1 day share price return of 1.63% and 7 day share price return of 2.00% helping the stock edge higher. The 1 year total...
BME:VIS
BME:VISFood

Viscofan (BME:VIS) Valuation Check After Q1 2026 Earnings Resilience

First quarter results and why they matter for Viscofan (BME:VIS) shareholders Viscofan (BME:VIS) has just reported first quarter 2026 results, with sales of €305.33 million versus €307.64 million a year earlier, while net income came in at €33.68 million compared with €31.36 million. See our latest analysis for Viscofan. The first quarter update comes after a steady share price run, with a 90 day share price return of 8.59% and a 12.83% year to date share price return from the current €60.7...
BME:CABK
BME:CABKBanks

CaixaBank (BME:CABK) Valuation Check After Q1 Net Income Climbs To €1,572 Million

Q1 earnings set fresh context for CaixaBank stock CaixaBank (BME:CABK) opened its 2026 story with first quarter net income of €1,572 million, compared with €1,470 million a year earlier. This result gives investors fresh data to reassess the stock. See our latest analysis for CaixaBank. The Q1 earnings update lands at a time when the stock is trading at €10.79, with a 1 month share price return of 3.95% and a 1 year total shareholder return of 61.50%. The 3 year total shareholder return is...
BME:SAB
BME:SABBanks

Sabadell (BME:SAB) Net Margin Slip To 28.3% Tests Bullish Profitability Narrative

Banco de Sabadell (BME:SAB) has opened Q1 2026 earnings season with Q4 2025 revenue of about €1.4b and net income of €386m, translating into basic EPS of €0.08 and a trailing twelve month EPS of €0.24. Over recent quarters, revenue has moved between €1.4b and €1.5b while quarterly EPS has ranged from €0.08 to €0.09, setting the backdrop for a trailing net margin of 28.3% compared with 31.2% a year earlier. For investors, this mix of steady top line, solid profitability levels and slightly...
BME:CIE
BME:CIEAuto Components

How Investors May Respond To CIE Automotive (BME:CIE) AGM Approvals, Dividend And Subsidiary Merger

CIE Automotive India’s 27th AGM, held on 29 April 2026, saw shareholders approve all eight resolutions, including a ₹7 per share dividend, major related-party transaction limits with Mahindra & Mahindra and CIE Automotive S.A., and the merger of wholly owned subsidiary CIE Aluminium Casting India Limited. The clean audit reports, unanimous voting outcomes, and disclosure of robust quarterly operational results collectively point to solid governance, business alignment with key partners, and...
BME:SAN
BME:SANBanks

Has Santander (BME:SAN) Run Too Far After Its 67% One Year Share Price Surge?

Investors may be asking whether Banco Santander at €10.38 is still offering value after a strong run, or whether much of the easier upside has already been realized. The share price performance has been strong, with returns of 1.8% over the past week, 5.8% over the past month, 1.2% year to date and 67.1% over the last year. The 3-year and 5-year returns stand at 259.4% and 273.6% respectively. Recent coverage has focused on Banco Santander's position within the European banking sector and...
BME:IDR
BME:IDRIT

Indra Sistemas (BME:IDR) Valuation Check After Q1 2026 Revenue Growth And Reaffirmed Guidance

Indra Sistemas (BME:IDR) drew attention after Q1 2026 results showed 15% revenue growth, a miss versus analyst expectations, and pre market weakness, while management reaffirmed full year revenue and EBIT targets. See our latest analysis for Indra Sistemas. At a share price of €48.81, the stock has seen a 2.4% 7 day share price return but a 10.6% 90 day share price decline, while the 1 year total shareholder return of 67.7% and very large 5 year total shareholder return suggest earlier...
BME:AENA
BME:AENAInfrastructure

A Look At Aena S.M.E (BME:AENA) Valuation After Strong Q1 2026 Earnings Update

Earnings snapshot and what just changed Aena S.M.E (BME:AENA) just released its Q1 2026 results, reporting sales of €1,469.32m and net income of €329.42m, compared with €1,309.88m and €301.31m a year earlier. Basic and diluted earnings per share from continuing operations were €0.22, compared with €0.20 in the same period last year. This gives investors fresh data to reassess the stock after a weak past 3 months. See our latest analysis for Aena S.M.E. The Q1 report arrives after a weaker...